Skip to content
Screener

Alto Neuroscience ANRO Market capitalization

Market capitalization at other companies

Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$5.83B+136%
LBR
LB Pharmaceuticals IncLBRX
$707.12M
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$705.32M+31.9%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$1.99B+341%
MapLight Therapeutics, Inc. logo
MapLight Therapeutics, Inc.MPLT
$862.73M
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$4.33B+15.5%

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Enterprise value$863.26M-2,281%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Computed from the period-end share price: $718.14M.

The source filing: Alto Neuroscience’s 10-Q, filed May 13, 2026. Open the filing →

Filed
May 13, 2026, 7:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001999480-26-000012

FAQ

What is Alto Neuroscience's market capitalization?
Alto Neuroscience (ANRO) reported market capitalization of $718.14M in Q1 2026.
How has Alto Neuroscience's market capitalization changed year-over-year?
Alto Neuroscience's market capitalization increased by 1128.1% year-over-year, from $58.48M to $718.14M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Alto Neuroscience's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude